×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Evaluating Potential Contribution of Social Media to Postmarketing Medication Safety Surveillance
Session Chair(s)
Preciosa M. Coloma, MD, PhD, MSc, RPh
Assistant Professor of Pharmacoepidemiology and Medical Informatics
Erasmus MC University Medical Center, Netherlands
Social Media and Pharmacovigilance
Learning Objective : Provide an overview of the potential usefulness of various social media data sources for postmarketing medication safety surveillance; Discuss various approaches to evaluating the potential contribution of social media data sources to postmarketing medication safety surveillance.
Speaker(s)
Social Media and Pharmacovigilance
Stella Stergiopoulos, MPH, MS
EQRx, United States
Director, Health Economic and Outcomes Research
Evaluating Medication Safety and Effectiveness Using Patient-Generated Data
Sally Okun, BSN, MHS, MBA, RN
Clinical Trials Transformation Initiative (CTTI), United States
Executive Director
Reinventing Safety: What Will It Take to Realize the Promise of Digital Pharmacovigilance and Social Media?
Michael A. Ibara, PharmD
Elligo Health Research, United States
Chief Data Officer
Have an account?